BridgeBio Pharma Inc.
(BBIO)
undefined
undefined%
At close: undefined
27.49
-0.04%
After-hours Dec 13, 2024, 04:15 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | 9.30M | 77.65M | 69.72M | 8.25M | 40.56M | - | - |
Cost of Revenue | 2.45M | 3.43M | 3.11M | 3.09M | 2.50M | - | 260.00K |
Gross Profit | 6.86M | 74.21M | 66.60M | 5.16M | 38.06M | - | -260.00K |
Operating Income | -607.37M | -471.87M | -579.75M | -474.48M | -266.24M | -183.66M | -43.86M |
Interest Income | 18.04M | 7.54M | 1.13M | 4.01M | 8.91M | 2.00M | 39.00K |
Pretax Income | -653.25M | -484.65M | -586.45M | -505.49M | -288.58M | -169.45M | -43.83M |
Net Income | -643.20M | -493.96M | -639.30M | -483.93M | -260.44M | -130.75M | -30.57M |
Selling & General & Admin | 150.59M | 143.19M | 192.21M | 145.68M | 94.35M | 43.59M | 13.30M |
Research & Development | 455.71M | 402.90M | 454.14M | 337.05M | 209.95M | 140.07M | 30.56M |
Other Expenses | 7.93M | 100.45M | 35.82M | 1.63M | -1.21M | -1.29M | - |
Operating Expenses | 614.23M | 546.09M | 646.35M | 482.73M | 304.30M | 183.66M | 43.86M |
Interest Expense | 81.29M | 80.44M | 46.78M | 36.66M | 8.77M | 2.55M | 13.00K |
Selling & Marketing Expenses | - | - | - | - | - | - | - |
Cost & Expenses | 616.67M | 546.09M | 646.35M | 482.73M | 306.80M | 183.66M | 43.86M |
Income Tax | - | 9.31M | 52.84M | -21.56M | -28.15M | 16.76M | -13.49M |
Shares Outstanding (Basic) | 162.79M | 147.47M | 144.36M | 118.00M | 105.10M | 92.33M | 92.33M |
Shares Outstanding (Diluted) | 162.79M | 147.47M | 144.36M | 118.00M | 105.10M | 92.33M | 92.33M |
EPS (Basic) | -3.95 | -3.35 | -4.43 | -4.1 | -2.48 | -1.42 | -0.33 |
EPS (Diluted) | -3.95 | -3.35 | -4.43 | -4.1 | -2.48 | -1.42 | -0.33 |
EBITDA | -565.47M | -397.44M | -533.83M | -465.75M | -279.82M | -183.41M | -43.56M |
Depreciation & Amortization | 6.49M | 6.77M | 5.84M | 3.09M | 859.00K | 245.00K | 260.00K |